In Response: We have reviewed the comments by Klabunde et al. and have provided detailed responses to each of the issues raised.
First, we address the issue that the data reported in our study (1) differ from those reported in studies by Swan et al. (2) and Seeff et al. (3) that also analyzed the 2000 National Health Interview Survey (NHIS). The study by Swan et al. only provides colorectal cancer screening information stratified by gender, whereas the study by Seeff et al. (which was published when our manuscript was already under review) provides overall colorectal cancer screening rates. The results from our study are not directly comparable with either of these studies for several reasons:
(a) The time interval used to assess compliance with endoscopy screening differs. We used 5 years for sigmoidoscopy and 10 years for colonoscopy. If a person reported unknown endoscopy, they were excluded from our sample (a limitation we clearly note in Discussion because we had to assign individuals to a specific colorectal cancer test).
Given these differences, the rates are not directly comparable and potentially due to the inclusion of proctoscopies, the rates reported by Swan et al. and Seeff et al. overestimate true population compliance rates and our results underestimate them due to the exclusion of ''unknown'' endoscopies. Second, the authors indicate that we are advocating a position different from that of the U.S. Preventive Services Task Force. We have devoted a large paragraph in Introduction and Discussion to current guideline recommendations for colorectal cancer screening, and we specifically state in the discussion section that ''several tests are currently recommended for colorectal cancer screening.'' Each of these tests has different features and none clearly emerges as the ''gold standard.'' Fecal occult blood test is the least invasive test, whereas colonoscopy is the most accurate. The authors have ignored our large paragraphs and have focused on a phrase we had in Materials and Methods that was merely indicating that due to recent studies (4) colonoscopy was now emerging as an important screening tool (specifically as the most effective test for detecting adenomas and cancers), whereas in the past it was considered primarily for diagnosis. Certainly, a poor choice of words on our part, but this phrase has been pulled out of context and misinterpreted.
Third, we do agree that it is impossible to know whether the respondents accurately identified sigmoidoscopies and colonoscopies. These are clearly the drawbacks of self-reports that are not verified through medical record abstractions or other means to ascertain validity and we have reported this as a limitation of our study. Furthermore, this drawback not only impacts the reporting of sigmoidoscopies and colonoscopies but also other tests and timing of the tests reported in the NHIS. There is ongoing discussion and research as to whether selfreports of fecal occult blood tests are underreported or overreported (5) .
Fourth, we acknowledge that the NHIS is an in-person interview survey and not a telephone survey, an error that was unfortunately overlooked during our internal review process. The authors also indicate that we did not report on combined tests, such as fecal occult blood test and sigmoidoscopy, which is recommended by guidelines. In our discussion, we provide the explanation that ''sufficient sample for combined fecal occult blood test and sigmoidoscopy testing was not available.'' Finally, we do agree that the NHIS is a very valuable tool that is a great resource to all researchers. The richness of the data in the NHIS allows for a variety of approaches and methods, each with their own advantages and disadvantages. As discussed, the NHIS is not without several limitations. Future efforts to collect more detailed information on all colorectal cancer screening tests, specifically distinguishing between colonoscopy and sigmoidoscopy, will be valuable to policy makers as there is a significant body of literature that indicates that patients have preferences for specific tests (6) and all endoscopic tests are not perceived equally. In addition, a limitation we have noted in our study is that the 2000 NHIS did not include doublecontrast barium enema (a recommended colorectal cancer screening test) and, therefore, none of the three studies discussed here include all the recommended colorectal cancer screening tests. We hope that the discussions raised by our study will increase awareness on the type of information and quality of the data available in the NHIS and other sources of data on colorectal cancer screening and lead to improved efforts to gather more comprehensive data in the future.
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